Leptomeningeal disease (LMD) in patients (pts) with metastatic melanoma (MM): Survival analysis of a contemporary cohort

I. C. Glitza, C. Saberian,J. Simon, S. Duncan, R. Amaria,M. Davies,A. Diab,J. Mcquade,S. Patel,H. A. Tawbi,C. Yee,M. Wong, I. McCutcheon, D. Milton, S. Ferguson

Annals of Oncology（2022）

引用 0|浏览0

暂无评分

摘要

Previous review of the overall survival (OS) of 178 pts with LMD from MM diagnosed between 1999-2015 showed a dismal OS of only 3.5 months (mos). Here we present a contemporary analysis to assess if outcomes had improved with the many changes in systemic therapies for MM pts with LMD since 2015.

查看译文

关键词

metastatic melanoma,283mo leptomeningeal disease,lmd

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要